W Janni
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Bone health and treatments
- Cancer Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 58
- Cancer Treatment and Pharmacology 22
- Cancer Cells and Metastasis 21
- HER2/EGFR in Cancer Research 11
- Cancer Diagnosis and Treatment 7
-
- Advanced Breast Cancer Therapies 20
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Klaus Pantel (18 shared papers)Harald Sommer (6 shared papers)Brigitte Rack (19 shared papers)F. Hepp (4 shared papers)Stephan Braun (3 shared papers)G. Riethmüller (1 shared paper)F Willgeroth (2 shared papers)Christian Schindlbeck (12 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer Research (9 papers)The Breast (5 papers)European Journal of Cancer (5 papers)Annals of Oncology (4 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
W Janni
63 papers receiving 457 citations
Peers
Comparison fields: 5 of 43
- Oncology 310
- Cancer Research 154
- Radiology, Nuclear Medicine and Imaging 73
- Pulmonary and Respiratory Medicine 86
- Urology 6
Countries citing papers authored by W Janni
This map shows the geographic impact of W Janni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Janni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Janni more than expected).
Fields of papers citing papers by W Janni
This network shows the impact of papers produced by W Janni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Janni. The network helps show where W Janni may publish in the future.
Co-authors
The 25 scholars most cited alongside W Janni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. | 1999 | 110 |
| 2 | 2010 | 71 | |
| 3 | 2009 | 56 | |
| 4 | 2001 | 29 | |
| 5 | 2008 | 22 | |
| 6 | 2016 | 21 | |
| 7 | 2011 | 13 | |
| 8 | 2004 | 13 | |
| 9 | 2011 | 12 | |
| 10 | 2001 | 11 | |
| 11 | 2005 | 6 | |
| 12 | 2009 | 5 | |
| 13 | 2003 | 5 | |
| 14 | 2012 | 5 | |
| 15 | 2011 | 5 | |
| 16 | 2009 | 4 | |
| 17 | 2009 | 4 | |
| 18 | 2009 | 4 | |
| 19 | 2004 | 4 | |
| 20 | 2024 | 4 |
About W Janni
W Janni is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Surgery, having authored 73 papers that have together received 471 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (29 papers), Cancer Treatment and Pharmacology (22 papers), Cancer Cells and Metastasis (21 papers), Advanced Breast Cancer Therapies (20 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Oncology (310 citations), Cancer Research (154 citations), Radiology, Nuclear Medicine and Imaging (73 citations), Pulmonary and Respiratory Medicine (86 citations) and Urology (6 citations). W Janni has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Klaus Pantel, Harald Sommer, Brigitte Rack, F. Hepp, Stephan Braun, G. Riethmüller, F Willgeroth, Christian Schindlbeck, B. Strobl and Tanja Fehm. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Breast, European Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.